|
1
|
Liang W, Gao B, Fu P, Xu S, Qian Y and Fu
Q: The miRNAs in the pathgenesis of osteosarcoma. Front Biosci
(Landmark Ed). 18:788–794. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valery PC, Laversanne M and Bray F: Bone
cancer incidence by morphological subtype: A global assessment.
Cancer Causes Control. 26:1127–1139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Debebe Z and Rathmell WK: Ror2 as a
therapeutic target in cancer. Pharmacol Ther. 150:143–148. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geng S, Zhang X, Chen J, Liu X, Zhang H,
Xu X, Ma Y, Li B, Zhang Y, Bi Z and Yang C: The tumor suppressor
role of miR-124 in osteosarcoma. PLoS One. 9:e915662014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang L, Deng Z, Shatseva T, Yang J, Peng
C, Du WW, Yee AJ, Ang LC, He C, Shan SW and Yang BB: MicroRNA
miR-93 promotes tumor growth and angiogenesis by targeting
integrin-β8. Oncogene. 30:806–821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ansari MH, Irani S, Edalat H, Amin R and
Roushandeh Mohammadi A: Deregulation of miR-93 and miR-143 in human
esophageal cancer. Tumour Biol. 37:3097–3103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu MH, Han C, Srivastava AK, Cul T, Zou N,
Gao ZQ and Wang QE: miR-93 promotes TGF-β-induced
epithelial-to-mesenchymal transition through downregulation of
NEDD4L in lung cancer cells. Tumour Biol. 37:5645–5651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawano M, Tanaka K, Itonaga I, Ikeda S,
Iwasaki T and Tsumura H: microRNA-93 promotes cell proliferation
via targeting of PTEN in osteosarcoma cells. J Exp Clin Cancer Res.
34:762015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dutto I, Tillhon M, Cazzalini O, Stivala
LA and Prosperi E: Biology of the cell cycle inhibitor p21
(CDKN1A): Molecular mechanisms and relevance in chemical
toxicology. Arch Toxicol. 89:155–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu M, Huang W, Bao N, Zhou G and Zhao J:
The flavonoid ampelopsin inhibited cell growth and induced
apoptosis and G0/G1 arrest in human osteosarcoma MG-63 cells in
vitro. Pharmazie. 70:388–393. 2015.PubMed/NCBI
|
|
17
|
Chen X, Deng M, Ma L, Zhou J, Xiao Y, Zhou
X, Zhang C and Wu M: Inhibitory effects of forkhead box L1 gene on
osteosarcoma growth through the induction of cell cycle arrest and
apoptosis. Oncol Rep. 34:265–271. 2015.PubMed/NCBI
|
|
18
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma overview. Rheumatol Ther. Dec 8–2016.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2^(−delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
20
|
Chang Z, Huo L, Li K, Wu Y and Hu Z:
Blocked autophagy by miR-101 enhances osteosarcoma cell
chemosensitivity in vitro. ScientificWorldJournal. 2014:7947562014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of miR-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Tan W, Neo TW, Aung MO, Wasser S,
Lim SG and Tan TM: Role of the miR-106b-25 microRNA cluster in
hepatocellular carcinoma. Cancer Sci. 100:1234–1242. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang L, Wang C, Lei F, Zhang L, Zhang X,
Liu A, Wu G, Zhu J and Song L: miR-93 promotes cell proliferation
in gliomas through activation of PI3K/Akt signaling pathway.
Oncotarget. 6:8286–8299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li G, Ren S, Su Z, Liu C, Deng T, Huang D,
Tian Y, Qiu Y and Liu Y: Increased expression of miR-93 is
associated with poor prognosis in head and neck squamous cell
carcinoma. Tumour Biol. 36:3949–3956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and
Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of
tumor suppressor gene FUS1. Mol Cancer Res. 7:1234–1243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C,
Li H, O'Malley YQ, Askeland RW, Sugg S, Liu M, et al: MiR-93
enhances angiogenesis and metastasis by targeting LATS2. Cell
Cycle. 11:4352–4365. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohkoshi S, Yano M and Matsuda Y: Oncogenic
role of p21 in hepatocarcinogenesis suggests a new treatment
strategy. World J Gastroenterol. 21:12150–12156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Strzalka W and Ziemienowicz A:
Proliferating cell nuclear antigen (PCNA): A key factor in DNA
replication and cell cycle regulation. Ann Bot. 107:1127–1140.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang L, Huang J, Li L, Chen Y, Chen X,
Zhao X and Yang D: MicroRNA-93 promotes ovarian granulosa cells
proliferation through targeting CDKN1A in polycystic ovarian
syndrome. J Clin Endocrinol Metab. 100:E729–E738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini
M, et al: E2F1-regulated microRNAs impair TGFbeta-dependent
cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell.
13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim YK, Yu J, Han TS, Park SY, Namkoong B,
Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK and Kim VN: Functional links
between clustered microRNAs: Suppression of cell-cycle inhibitors
by microRNA clusters in gastric cancer. Nucleic Acids Res.
37:1672–1681. 2009. View Article : Google Scholar : PubMed/NCBI
|
